Back to search
FDAFDA · Food and drugs·Recall number D-1087-2014

Clonazepam Tablets, USP 2 mg 100 tablets Manufactured by: Actavis Elizabeth LLC 200 Elmora Avenue, Elizabeth, NJ 0737 USA NDC 0228-3005-11 packaged in White/Round HDPE 75 CC with white/round plastic 33 mm CRC closure shipped in corrugated 75 cc carton (24 bottles/carton)

Published March 5, 2014 · Recall initiated: November 6, 2013

Summary

FDA records drug Class II recall D-1087-2014, published March 5, 2014 and initiated November 6, 2013. Recalling firm: Actavis Elizabeth LLC; Status: Terminated; Reported quantity: 13,608 bottles; Lot: lot 58468552 Exp. 05/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: During routine stability testing one tablet was found with tablet weight below specification.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Actavis Elizabeth LLC
Distributor
Nationwide
Lot
lot 58468552 Exp. 05/15
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Clonazepam Tablets, USP 2 mg 100 tablets Manufactured by: Actavis Elizabeth LLC 200 Elmora Avenue, Elizabeth, NJ 0737 USA NDC 0228-3005-11 packaged in White/Round HDPE 75 CC with white/round plastic 33 mm CRC closure shipped in corrugated 75 cc carton (24 bottles/carton) recalled?

Yes. FDA published recall D-1087-2014 on March 5, 2014. Reported hazard: Subpotent Drug: During routine stability testing one tablet was found with tablet weight below specification.

What should I do if I have this product?

Voluntary: Firm initiated · Letter